WordNet

expose to a chance of loss or damage; "We risked losing a lot of money in this venture"; "Why risk your life?"; "She laid her job on the line when she told the boss that he was wrong" (同)put on the line, lay on the line
a venture undertaken without regard to possible loss or injury; "he saw the rewards but not the risks of crime"; "there was a danger he would do the wrong thing" (同)peril, danger
the probability of being exposed to an infectious agent (同)risk of exposure
the probability of becoming infected given that exposure to an infectious agent has occurred (同)risk of infection
newly come into prominence; "a rising young politician"
advancing or becoming higher or greater in degree or value or status; "a rising trend"; "a rising market"

PrepTutorEJDIC

『危険』;危害(損害)を受ける可能性《+『of』+『名』(do『ing』)》 / 〈生命など〉‘を'『危険にさらす』 / …‘を'危険(失敗,損失など)を覚悟してする
〈U〉(…が)上がること,(…の)上昇;昇進《+『of』+『名』》 / 〈U〉起床 / 〈C〉蜂起,反乱 / 上がる,強まる,高まる / 成長する,発達中の,上り坂にある
ほぼ(…)歳

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人における意思決定能力の評価 assessment of decision making capacity in adults
2. 乾癬における合併疾患 comorbid disease in psoriasis
3. ワルファリンおよびその他のビタミンK拮抗剤の治療使用 therapeutic use of warfarin and other vitamin k antagonists
4. 輸血拒否の患者に対するアプローチ the approach to the patient who refuses blood transfusion
5. 癌疼痛のマネージメント：オピオイド系薬剤を使用している患者の一般原則およびリスクマネージメント cancer pain management general principles and risk management for patients receiving opioids

English Journal

A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci.

Singleton A, Hardy J.AbstractThe dominant and sometimes competing theories for the aetiology of complex human disease have been the common disease, common variant (CDCV) hypothesis, and the multiple rare variant (MRV) hypothesis. With the advent of genome wide association studies and of second-generation sequencing, we are fortunate in being able to test these ideas. The results to date suggest that these hypotheses are not mutually exclusive. Further, initial evidence suggests that both MRV and CDCV can be true at the same loci, and that other disease-related genetic mechanisms also exist at some of these loci. We propose calling these, pleomorphic risk loci, and discuss here how such loci not only offer understanding of the genetic basis of disease, but also provide mechanistic biological insight into disease processes.
Human molecular genetics.Hum Mol Genet.2011 Oct 15;20(R2):R158-62. Epub 2011 Aug 29.
The dominant and sometimes competing theories for the aetiology of complex human disease have been the common disease, common variant (CDCV) hypothesis, and the multiple rare variant (MRV) hypothesis. With the advent of genome wide association studies and of second-generation sequencing, we are fort
PMID 21875901

Risk Factors for Medication Non-Adherence in an HIV Infected Population in the Dominican Republic.

Harris J, Pillinger M, Fromstein D, Gomez B, Garris I, Kanetsky PA, Tebas P, Gross R.SourceDepartment of Medicine (Resident), Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
AIDS and behavior.AIDS Behav.2011 Oct;15(7):1410-5.
High levels of medication adherence are central to HIV treatment success. Barriers to medication adherence may differ by cultural setting. We aimed to determine risk factors for medication non-adherence in HIV infected individuals in the Dominican Republic. Adherence was measured in 300 individuals
PMID 20721615

Japanese Journal

Copulaの多重従属な競合リスクモデルにおける識別可能性問題への応用

米山寛二,葉光毅,松崎友美 [他]
兵庫県立大学環境人間学部研究報告 (12), 79-85, 2010
NAID 40017096650

Surveillance in Barrett's Esophagus : A Failed Premise

INADOMI John M.
Keio journal of medicine 58(1), 12-18, 2009-03-01
… Cost-effectiveness analysis was employed to compare competing strategies of management for patients with Barretts esophagus to determine whether surveillance strategies using alternative biomarkers could out-perform dysplasia based surveillance, and whether new techniques for eradicating Barretts metaplasia would constitute cost-effective strategies.Results: Surveillance did not improve long-term survival among veterans diagnosed with esophageal adenocarcinoma. …
NAID 10026202499

Related Pictures

Competing risk regression analysis of predictors in the training cohort | Download Competing risks need to be considered in survival analysis models for cardiovascular Univariate competing risk analyses of diabetes and anti-diabetic | Download Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Decision curve analysis for the Competing Risk Nomogram and the 8th TNM | Download Competing-risk Cumulative Incidence of Distant Failure | Download Scientific Diagram Cumulative incidence curves of all-cause death. The competing risk | Download Cumulative incidence function with death as competing risk of the time | Download